Healthcare tech company Medtronic have announced they have received approval from the FDA for their Simplera Sync sensor to be used with the MiniMed 780G system. The Simplera Sync is Medtronic’s latest Continuous Glucose Monitor (CGM). The all-in-one disposable system promises greater flexibility and unique functionality.
The approval relates to the CGM’s use with Medtronic’s MiniMed 780G insulin pump system, sporting an algorithm that can “automatically anticipate, adjust, and correct glucose levels every 5 minutes, 24/7.”
The insulin delivery system offers features like Meal Detection, which automatically delivers insulin in response to a patient’s rising sugar levels. This helps them stay in the recommended glucose range more often, cutting down on spikes due to patient error.
"We're committed to driving innovation that makes life easier for those living with diabetes so they can forget about their diabetes as much as possible throughout the day," said Que Dallara, EVP and President of Medtronic Diabetes.
She continued: "Our MiniMed 780G system delivers advanced diabetes technology for so many around the world, and we're excited to continue evolving this experience with expanded CGM options —including our Simplera Sync sensor, which we look forward to bringing to people living with diabetes in the U.S."